Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             240 results found
no title author magazine year volume issue page(s) type
1 8.7-05 1989
26 S p. 98-
1 p.
article
2 6.3-04 Absence of lymphocyte proliferation of synovial fluid mononuclear cell(SFMC) in response to tetanus toxoide(TT) in rheumatoid arthritis Iglesias, A
1989
26 S p. 59-
1 p.
article
3 3.2-01 A genetically controlled pairing anomaly between HLA-DQα and HLA-DQβ molecules Kwok, W.W
1989
26 S p. 16-
1 p.
article
4 4.2-03 A genetically distinct family of HLA-A antigens comprising A29, A31, and Aw33, but not A30 Kato, K
1989
26 S p. 27-
1 p.
article
5 8.1-08 Algorithm to increase the number of kidneys for highly sensitized patients based on identification of acceptable private and public antigens Thompson, John S
1989
26 S p. 79-
1 p.
article
6 7.2-07 Altered lymphocyte phenotype frequency patterns in humans exposed to halogenated aromatic hydrocarbons McConnachie, P.R
1989
26 S p. 66-
1 p.
article
7 American society for histocompatibility and immunogenetics 15th annual meeting program 1989
26 S p. xx-xxxvi
nvt p.
article
8 2.2-05 A monocyte specific antigen linked to HLA-DX recognised by a T cell clone Farrell, C
1989
26 S p. 11-
1 p.
article
9 5.4-08 Analysis of HLA sequence polymorphism using DNA amplification and oligonucleotide hybridization Baxter-Lowe, L.A
1989
26 S p. 43-
1 p.
article
10 6.2-13 Analysis of restriction fragment length polymorphism of class II MHC in pauciarticular juvenile rheumatoid arthriris Barron, K.S
1989
26 S p. 56-
1 p.
article
11 2.2-01 Analysis of the allospecific T cell response to HLA-DR2 using DR2-transfected murine L cell stimulators Jaraquemada, Dolores
1989
26 S p. 9-
1 p.
article
12 5.4-01 A new analysis of DRw6 with group-specific amplification: DRB1, DRB3 and DQB alleles Shumway, W
1989
26 S p. 39-
1 p.
article
13 7.1-03 A new differentiation antigen, NDA5, involved in the amplification of primary and memory T cell responses Suciu-Foca, N
1989
26 S p. 62-
1 p.
article
14 7.1-04 A new differentiation antigen NDA4 involved in the growth and functional maturation of T and of B lymphocytes Harris, P
1989
26 S p. 63-
1 p.
article
15 6.2-10 An HLA-DR3 DPW1 extended haplotype is associated with coeliac disease Hall, M.A
1989
26 S p. 54-
1 p.
article
16 8.1-04 An incompatible six antigen-matched donor Cooper, T
1989
26 S p. 77-
1 p.
article
17 9.3-03 A non-classical class I antigen, HLA-G is expressed in human first trimester trophoblasts Kovats, S
1989
26 S p. 104-
1 p.
article
18 4.2-02 A novel HLA-class I allele derived from a recombination between B∗2705 and Bw61 Choo, S.Y
1989
26 S p. 26-
1 p.
article
19 Antibodies to polymorphic HLA class I epitopes in HLA-transgenic mice Hammerling, U
1989
26 S p. 117-
1 p.
article
20 8.3-02 Antibody development in patients receiving anti-thymocyte serum Crowe, D.O
1989
26 S p. 87-
1 p.
article
21 8.4-05 Anti-HLA-A2 antibodies purified from a highly sensitized patient DeVito, L.D
1989
26 S p. 91-
1 p.
article
22 8.4-04 Anti-idiotypic antibodies: A mechanism of tolerance to non-inherited maternal HLA antigens Phelan, D.L
1989
26 S p. 90-
1 p.
article
23 8.4-08 Anti-idiotypic antibodies and soluble HLA antigens control the evolution of chronic humoral rejection of heart and kidney allografts Suciu-Foca, N
1989
26 S p. 92-
1 p.
article
24 5.1-03 Anti-idiotypic IgM revealed by dithiothreitol? Tyler, J.D
1989
26 S p. 36-
1 p.
article
25 7.4-04 Anti-RO/SSA autoantibodies are associated with polymorphisms of the T cell receptor beta locus Frank, M.B
1989
26 S p. 71-
1 p.
article
26 1.1-03 Antisera to HLA epitopes Han, H
1989
26 S p. 3-
1 p.
article
27 8.1-14 An unofficial examination of six-antigen match transplants Takemoto, S
1989
26 S p. 82-
1 p.
article
28 ASHI officers 1989
26 S p. ii-vi
nvt p.
article
29 ASHI scholars 1989
26 S p. xvi-
1 p.
article
30 ASHI's 16th annual meeting 1989
26 S p. xiv-xv
nvt p.
article
31 5.4-04 A simple test to rapidly determine HLA-DQB1 molecular alleles Fritsch, R
1989
26 S p. 41-
1 p.
article
32 5.4-05 A simplified method for isolation of bacterial plasmids Olivo, A
1989
26 S p. 41-
1 p.
article
33 4.1-07 Assessment of binding to the conserved upstream sequences of the class II major histocompatibility complex via the in vitro transcription assay Didier, D.K
1989
26 S p. 23-
1 p.
article
34 6.2-06 Assessment of HLA-DP association with celiac disease Colonna, M
1989
26 S p. 52-
1 p.
article
35 9.7-03 Association of four class III genomic markers mapping near TNF with extended HLA-A-B-DR haplotypes Pei, J
1989
26 S p. 109-
1 p.
article
36 6.2-01 Association of uveitis following extracapsular cataract extraction with HLA-DQB1 restriction fragments Casilio-Lonardo, E
1989
26 S p. 50-
1 p.
article
37 9.7-04 A T cell receptor Vb gene fragment related RFLP defines a polymorphic marker in Northern European populations Maksymowych, W.P
1989
26 S p. 109-
1 p.
article
38 Awards 1989
26 S p. xiii-
1 p.
article
39 3.2-04 Binding of an influenze hemagglutinin-derived peptide to HLA-DR molecules Roche, P.A
1989
26 S p. 17-
1 p.
article
40 5.3-01 Binding of peptide to HLA in B cell lines Frumento, G
1989
26 S p. 39-
1 p.
article
41 cDNA clones for HLA class II X box binding proteins Konigorski, Susanne
1989
26 S p. 113-
1 p.
article
42 2.1-02 Cellular and molecular characterization of a Dw2 variant Stackhouse, B.L
1989
26 S p. 8-
1 p.
article
43 Cellular basis of the proliferative response of human T cells in response to mouse xenoantigens Alter, B.J
1989
26 S p. 116-
1 p.
article
44 9.5-01 Characterization of a murine homolog of Y box binding protein Woulfe, S.L
1989
26 S p. 106-
1 p.
article
45 4.1-09 Characterization of the interaction of two DNA-binding proteins with the class II gene promoter Woulfe, S.L
1989
26 S p. 24-
1 p.
article
46 4.3-15 Characterization of two DR“6X” variant haplotypes designated DHAG and DEWP Petersdorf, E
1989
26 S p. 35-
1 p.
article
47 9.1-01 Class III typing as a strategy for identifying potential bone marrow donors Welch, T.R
1989
26 S p. 102-
1 p.
article
48 4.1-11 Cloning of the YBI multi-gene family Zacheis, M
1989
26 S p. 25-
1 p.
article
49 6.2-02 Comparative study of HLA associations and C4A gene deletion in French-Canadian and non-French-Canadian caucasians with systemic lupus erythematosus (SLE) Goldstein, R
1989
26 S p. 50-
1 p.
article
50 5.1-01 Comparison of flow cytometry (FC) and antiglobulin (AHG) augmented cytotoxicity crossmatching Reynolds, B.A
1989
26 S p. 35-
1 p.
article
51 8.7-01 Correlation between binding of cyclosporine metabolites to peripheral blood mononuclear cells and immunosuppression in vitro McKenna, R.M
1989
26 S p. 96-
1 p.
article
52 4.3-07 Correlation between RFLP class II pattern and MLC reactivity in HLA-AB DR phenotypically identical unrelated bone marrow reciepient and donor pairs Goldmann, S.F
1989
26 S p. 31-
1 p.
article
53 5.2-02 Covalent coupling of biomolecules onto activated polystyrene surfaces Rasmussen, S.E
1989
26 S p. 38-
1 p.
article
54 9.3-02 Crossreactive idiotypes on antitrophoblast antibodies McIntyre, J.A
1989
26 S p. 104-
1 p.
article
55 8.7-03 Cyclosporine metabolites in immunosuppression and nephrotoxicity Rosano, Thomas G
1989
26 S p. 97-
1 p.
article
56 8.2-05 Cytotoxic and proliferative cell clones with anti-donor reactivity from a patient transplanted for severe combined immunodeficiency disease Keever, C.A
1989
26 S p. 86-
1 p.
article
57 5.5-02 Cytotoxic flow crossmateches Wetzsteon, P.J
1989
26 S p. 44-
1 p.
article
58 1.3-05 Definition of DRB3 alleles by serology Barbetti, A.A
1989
26 S p. 6-
1 p.
article
59 6.1-07 Demyelinating disease of the peripheral and central nervous systems — HLA linkage disequilibrium similarities Doran, Trevor J
1989
26 S p. 48-
1 p.
article
60 1.1-01 Detection of new HLA-ABC variants through the international cell exchange, 1988–1989 Lau, M
1989
26 S p. 3-
1 p.
article
61 4.3-05 Detection of variants of HLA-DR1 by allele-specific amplification of DNA by the polymerase chain reaction (PCR) and DOT hybridization with oligonucleotide probes Gao, X
1989
26 S p. 30-
1 p.
article
62 8.1-10 Determinants of outcome in renal transplantation with an historical positive crossmatch Bollinger, R.R
1989
26 S p. 80-
1 p.
article
63 8.1-09 Development of human anti-mouse antibody following in vivo therapy during renal allograft rejection with T10B9 and/or OKT3 Brown, S.A
1989
26 S p. 79-
1 p.
article
64 8.1-05 Development of human endothelial hybrid cell lines expressing endothelial specific antigens Luo, Y
1989
26 S p. 77-
1 p.
article
65 8.3-01 Development of in vitro assay using cellular activation signals to monitor cyclosporine immunosuppression Kimball, P
1989
26 S p. 87-
1 p.
article
66 7.3-01 Dialysable suppressive factor related to E-receptors(CD2) Musatti, C.C
1989
26 S p. 67-
1 p.
article
67 7.2-05 Differential effects of HLA class I and II antigen matching on the activation of CD3, CD4 and CD8 T-cell subsets in the stable renal allograft recipient Shabtai, M
1989
26 S p. 65-
1 p.
article
68 2.3-04 Diminished stringency of HLA restriction with peptide concentration Doran, Trevor J
1989
26 S p. 14-
1 p.
article
69 3.2-07 Dissociation and reassociation of Ia-peptide complexes Lee, Jonathan M
1989
26 S p. 19-
1 p.
article
70 4.3-06 DNA typing for class II HLA antigens with allele-specific or group-specific amplification. Typing for subsets of HLA-DR4 Gao, X
1989
26 S p. 30-
1 p.
article
71 9.6-01 Documentation of canine bone marrow transplantation engraftment using minisatellite probes Gerlach, J.A
1989
26 S p. 107-
1 p.
article
72 6.2-08 Does ASP-57 confer protection to IDDM in oriental populations as well as in caucasians? Bao, M
1989
26 S p. 53-
1 p.
article
73 6.1-04 Do HLA antigens influence resistance to lung carcinoma? Romano, P.J
1989
26 S p. 47-
1 p.
article
74 8.5-01 Donor specific proliferative and cytotoxic responses of lymphocyte cultures propagated from endomyocardial biopsies and peripheral blood of heart transplant recipients Kaufman, C.L
1989
26 S p. 93-
1 p.
article
75 8.8-03 Donor specific transfusion (DST) does not normalize long term function or inflammatory mediator production by rat renal allografts Coffman, T.M
1989
26 S p. 100-
1 p.
article
76 8.8-02 Donor-specific transfusions down-regulate the generation of anti-donor cytotoxic T lymphocytes Hadley, G.A
1989
26 S p. 100-
1 p.
article
77 6.2-07 DP subtype association in cancer patients Mitsuishi, Y
1989
26 S p. 53-
1 p.
article
78 1.3-08 DQ alpha in the serological definition of RFLP defined DQw1 splits Doran, Trevor
1989
26 S p. 7-
1 p.
article
79 2.2-02 DRβ polymorphic residues that determine T cell allorecognition Rosen-Bronson, S
1989
26 S p. 9-
1 p.
article
80 2.3-01 DR7β1 structure-function relationships in antigen-specific T cell recognition Karr, R.W
1989
26 S p. 12-
1 p.
article
81 1.3-02 DRw12 and DRw8 in North American blacks and DR-blank haplotypes in Latino-American subjects Miller, S
1989
26 S p. 4-
1 p.
article
82 9.3-05 DRw6 in repeated spontaneous abortion of unknown etiology Segall, M
1989
26 S p. 105-
1 p.
article
83 4.3-11 DRw6-related DQ genes in American blacks Lee, K.W
1989
26 S p. 33-
1 p.
article
84 8.1-13 Early graft outcome with 6-HLA matched cadaveric kidneys Tyler, J.D
1989
26 S p. 81-
1 p.
article
85 8.8-05 Effect of donor HLA haplotype on donor-specific transfusion outcome Bean, M.A
1989
26 S p. 101-
1 p.
article
86 7.6-01 Effect of FK 506 and CsA on lymphocyte activation by calcium ionophore Elras, G
1989
26 S p. 73-
1 p.
article
87 8.1-03 Effect of positive antiglobulin crossmatch on cadaveric renal allograft function Teresi, G.A
1989
26 S p. 76-
1 p.
article
88 8.1-16 Effect of positive cross-match against donor B-lymphocytes in kidney transplantation. A prospective one center study Bignon, J.D
1989
26 S p. 83-
1 p.
article
89 6.3-02 Effect of viral infections and interferon on erythrocyte, plasma and platelet HLA Scornik, J.C
1989
26 S p. 58-
1 p.
article
90 9.2-01 Effects of cAMP on cytotoxic T cells Goeken, N.E
1989
26 S p. 102-
1 p.
article
91 8.7-02 Effects of human prolactin on human lymphocyte proliferation and cyclosporin a immunosuppression Bakkestad-Legare, Patty
1989
26 S p. 96-
1 p.
article
92 3.1-03 Epitope map of the HLA-B7 creg using affinity-purified alloantibodies Fuller, A.A
1989
26 S p. 15-
1 p.
article
93 8.1-02 Epitope matching for renal transplantation, a molecular approach Cecka, J.M
1989
26 S p. 76-
1 p.
article
94 7.6-04 Establishment of human CTL lines cytotoxic for both autologous and allogeneic EBV-transformed B cell targets from multiple sclerosis patients Morse, P.A
1989
26 S p. 75-
1 p.
article
95 5.5-03 Evaluation of automated crossmatch analysis Heller, M.J
1989
26 S p. 44-
1 p.
article
96 5.5-01 Evaluation of automated PRA analysis Heller, M.J
1989
26 S p. 43-
1 p.
article
97 Evaluation of natural antibody levels relevant to xenotransplantation Noreen, H.J
1989
26 S p. 116-
1 p.
article
98 10.1-03 Evaluation of the first 100 kidneys shared by the unos point system McClelland, J
1989
26 S p. 111-
1 p.
article
99 8.5-02 Evidence for cytotoxic T cell induction after sequential liver-kidney transplant Duffy, B.F
1989
26 S p. 94-
1 p.
article
100 Exhibitors 1989
26 S p. xxxvii-xlii
nvt p.
article
101 5.1-02 Experience with dithiothreitol crossmatching in a highly sensitized population Dwyer, D.D
1989
26 S p. 36-
1 p.
article
102 4.1-03 Expression of HLA-DR1 in a human class II mutant B cell line by co-transfection with DRA and DRB1 plasmid vectors Becker, Kevin G
1989
26 S p. 21-
1 p.
article
103 4.3-10 Extreme diversity of DRw13-related DRB1 alleles in American blacks Lee, K.W
1989
26 S p. 32-
1 p.
article
104 7.2-02 Flow cytometric analysis of T cell activation antigens Book, B.K
1989
26 S p. 64-
1 p.
article
105 Functional analysis of regulatory defects in HLA class II negative mutant cell lines Shookster, Linda
1989
26 S p. 113-
1 p.
article
106 4.3-14 Further DNA sequence microheterogeneity of the HLA-DR4/DW13 haplotype group: Importance of amino acid position 86 of the DR beta 1 chain for T cell recognition Lang, B
1989
26 S p. 34-
1 p.
article
107 1.3-06 Further heterogeneity of HLA-DR2 — “DR2.3” Mervart, H
1989
26 S p. 6-
1 p.
article
108 General information 1989
26 S p. x-xii
nvt p.
article
109 7.3-06 Generation of mixed lymphocyte reactions on CD8+ and CD4+ T subpopulations by a B-LCL lacking HLA class II antigens Jin, Z
1989
26 S p. 69-
1 p.
article
110 5.2-03 Generation of monoclonal anti-DQw7 and DQw8 antibodies utilizing allele specific DQ beta peptides Hoover, M.L
1989
26 S p. 38-
1 p.
article
111 7.3-04 Genetic control of trichosanthin-induced immunosuppression Bias, W.B
1989
26 S p. 68-
1 p.
article
112 6.3-01 Genetic predisposition to autoimmunity: Platelet and endothelial cell antibodies and nephritis Hashemi, S
1989
26 S p. 58-
1 p.
article
113 7.4-01 Genetic variation in sequences within the binding site of T cell receptor Vβ chains Robinson, Mary Ann
1989
26 S p. 70-
1 p.
article
114 8.6-02 Genomic HLA class II typing (DR, DQ and DP specificities), primary mixed lymphocytes reaction and G.V.H. disease: Retrospective study of 41 allogeneic marrow transplantations Moreau, P
1989
26 S p. 95-
1 p.
article
115 8.2-03 Graft-versus-host reaction, relapse and survival after HLA-nonidentical marrow transplants for malignancy Anasetti, C
1989
26 S p. 85-
1 p.
article
116 7.2-06 Heterogeneity of human CD8 molecules and anti CD8 antibodies Terry, L.A
1989
26 S p. 66-
1 p.
article
117 6.1-03 HLA and Kaposi's sarcoma in transplant patients Brunson, M.E
1989
26 S p. 46-
1 p.
article
118 4.1-02 HLA-AR: An inactivated class I locus that is related to HLA-A Zemmour, J
1989
26 S p. 20-
1 p.
article
119 3.1-02 HLA class I antigens on lymphocytes transduce signal by raising cytoplasmic calcium Dasgupta, J.D
1989
26 S p. 15-
1 p.
article
120 2.2-07 HLA class II molecules identical by sequence can be recognized differently by alloreactive T cell clones Termijtelen, A
1989
26 S p. 12-
1 p.
article
121 1.1-02 HLA class I public epitopes recognized by alloantisera: Correlation with amino acid sequences Hunter, J.B
1989
26 S p. 3-
1 p.
article
122 4.3-02 HLA-DR and DQ RFLP correlations with serology in caucasian and non-caucasian individuals: Characterization of a novel DRw16 RFLP in a Thai individual Howell, W.M
1989
26 S p. 28-
1 p.
article
123 8.7-04 HLA-DR2 and in vitro sensitivity to immunosuppressive drugs Lazda, V.A
1989
26 S p. 97-
1 p.
article
124 1.3-07 HLA DR/DQ linkage disequilibrium in haplotypes defined in a large trihybrid pedigree Layrisse, Z
1989
26 S p. 7-
1 p.
article
125 6.1-06 HLA-D region alloantigens and remission of disease in women with rheumatoid arthritis during pregnancy Lee Nelson, J
1989
26 S p. 48-
1 p.
article
126 6.2-04 HLA-DR1 is associated with susceptibility and HLA-DQw2 with resistance in Brazilian pemphigus foliaceus Moraes, J.R
1989
26 S p. 51-
1 p.
article
127 6.2-11 HLA-DR4 nucleotide sequence polymorphisms in rheumatoid arthritis Lanchbury, J.S.S
1989
26 S p. 55-
1 p.
article
128 4.3-13 HLA-DR typing by means of DNA amplification and non-radioactive allele-specific oligonucleotide hybridization Ferrara, G.B
1989
26 S p. 34-
1 p.
article
129 6.2-16 HLA DRw52“a” and RFLP-subtyping in mothers alloimmunized against PLA1 platelet antigen Valentin, N
1989
26 S p. 57-
1 p.
article
130 1.3-01 HLA-DRw13 associations with DQ alleles: DQw1, DQw7, DQw8 and DQw2 Miller, S
1989
26 S p. 4-
1 p.
article
131 6.1-05 HLA haplotypes in IDDM patients of mixed ethnic origin Esparza, B
1989
26 S p. 47-
1 p.
article
132 6.1-01 HLA typing in actinic prurigo; a new HLA association Sheridan, D.P
1989
26 S p. 45-
1 p.
article
133 6.1-09 HLA typing in cystic fibrosis arthritis and hypertrophic osteoarthropathy Rush, P.J
1989
26 S p. 49-
1 p.
article
134 How to use this book 1989
26 S p. ix-
1 p.
article
135 7.6-02 Human LAK cells induce single-strand nicks in human tumor cells Tomita, A
1989
26 S p. 74-
1 p.
article
136 1.3-03 Human monoclonal antibody MP8 detects a supertypic determinant encoded by DP beta alleles DPB2.1, DPB3, DPB4.2, DPB8, DPB9 and DPB10 Mazzoleni, O
1989
26 S p. 5-
1 p.
article
137 7.5-01 Human suppressor T-cell factor cross react with T lymphocytes from lower species Emara, M
1989
26 S p. 72-
1 p.
article
138 4.1-01 Human trophoblast expresses a non classical HLA class I molecule Ellis, Shirley A
1989
26 S p. 20-
1 p.
article
139 8.1-07 Hyperacute rejection: A case study Gordon, C.L
1989
26 S p. 78-
1 p.
article
140 7.2-01 Hyporesponsiveness of “naive” (CD45RA+) human T cells to multiple receptor-mediated stimuli but augmentation of response by costimuli Horgan, K.J
1989
26 S p. 63-
1 p.
article
141 7.4-02 Identification and characterization of a human T-cell receptor β chain transcriptional element Gottschalk, L
1989
26 S p. 70-
1 p.
article
142 4.3-09 Identification of a new DRβ3 allele Cotner, Tom
1989
26 S p. 32-
1 p.
article
143 5.4-02 Identification of 18 HLA-DP alleles with group-specific amplification of DNA and 15 oligonucleotide probes Fernandez-Vina, M
1989
26 S p. 40-
1 p.
article
144 4.1-12 Identification of the binding domain of a Y box binding protein McDaid, D.M
1989
26 S p. 25-
1 p.
article
145 2.3-03 Identification of the components of the class II-hemagglutinin peptide complex recognized by a human influenza-specific T cell clone Nygard, N.R
1989
26 S p. 13-
1 p.
article
146 9.3-04 Idiopathic spontaneous abortion; screening by flow cytometric crossmatch and mixed lymphocyte culture Chen, J.C
1989
26 S p. 105-
1 p.
article
147 Immunogenetic and cellular aspects of xenogeneic response Reinsmoen, N.L
1989
26 S p. 117-
1 p.
article
148 8.3-04 Immunogenetic and cellular basis of long-term renal graft acceptance Reinsmoen, N.L
1989
26 S p. 88-
1 p.
article
149 3.1-01 Immunoglobulin binding by HLA molecules Chia, David
1989
26 S p. 14-
1 p.
article
150 6.3-05 Immunologic evaluation of patients with psoriasis Nikaein, A
1989
26 S p. 60-
1 p.
article
151 8.7-06 Immunosuppresive property of clerodendron lectin Sandhu, H.S
1989
26 S p. 99-
1 p.
article
152 8.5-03 Impact of concurrent viral infection on cellular infiltration at a graft site Orosz, C.G
1989
26 S p. 94-
1 p.
article
153 8.1-15 Improved graft survival for AHG-XM and FCXM negative retransplant recipients Kerman, R.H
1989
26 S p. 82-
1 p.
article
154 2.2-06 Indirect response to allogeneic peptides Reinsmoen, N.L
1989
26 S p. 11-
1 p.
article
155 8.4-07 Induction of anti-idiotypic antibodies to anti-HLA antibodies after donor-specific transfusion in not sensitized kidney graft recipients Pohanka, E
1989
26 S p. 92-
1 p.
article
156 8.8-04 Induction of renal allograft enhancement by donor-specific transfusions — Requirement for HLA class II disparity Lazda, V.A
1989
26 S p. 101-
1 p.
article
157 4.1-08 Intensity of DNA-binding activity in nuclear extracts exhibits inverse correlation with levels of class II expression Klutho, Linda M
1989
26 S p. 23-
1 p.
article
158 7.3-02 Interferon-gamma in autologous and allogeneic mixed lymphocyte cultures Pazderka, F
1989
26 S p. 67-
1 p.
article
159 7.5-02 Intravenous immunoglobulin G inhibits T cell proliferation Mahoney, R.J
1989
26 S p. 72-
1 p.
article
160 8.3-03 In vivo clonal selection of T cells following haploidentical bone marrow transplantation for combined immunodeficiency Hoadley, C
1989
26 S p. 88-
1 p.
article
161 2.1-01 Is HLA-DW typing a direct or indirect reflection of HLA class II polymorphism? Gorski, J
1989
26 S p. 8-
1 p.
article
162 4.1-05 Isolation and characterization of a MHC class II negative human B cell line Guethlein, L.A
1989
26 S p. 22-
1 p.
article
163 5.4-06 Isolation and use of HLA class I-expressing transfectants prepared using genomic DNA Drover, S
1989
26 S p. 42-
1 p.
article
164 6.3-07 Isolation of islet cell reactive monoclonal antibodies from non-obese diabetic mice Valdivia, R
1989
26 S p. 60-
1 p.
article
165 8.1-12 Lack of T-cell tolerance of noninherited maternal HLA antigens Hadley, G.A
1989
26 S p. 81-
1 p.
article
166 9.6-02 LAK cell purging of syngeneic and allogeneic bone marrow Cramer, D.V
1989
26 S p. 107-
1 p.
article
167 4.2-04 Localization of a single amino acid which determines the HLA-B44.1 IEF subtype Fleischhauer, K
1989
26 S p. 27-
1 p.
article
168 Localization of the HLA 5′ flanking subregions binding to nuclear proteins Park, J.H
1989
26 S p. 115-
1 p.
article
169 7.6-03 Loss of serine esterase activity during CTL inactivation by a sensitive target Hommel-Berrey, G
1989
26 S p. 74-
1 p.
article
170 8.6-01 Lymphocyte functional alterations in graft versus host disease Jennings, C.D
1989
26 S p. 95-
1 p.
article
171 Map of Toronto and Metro 1989
26 S p. vii-
1 p.
article
172 8.2-01 Marrow grafting from HLA matched unrelated donors Beatty, P.G
1989
26 S p. 84-
1 p.
article
173 8.4-09 Maternal tolerance to the fetus: Regulatory networks involved in allogeneic tolerance Reed, E
1989
26 S p. 93-
1 p.
article
174 7.1-02 Maturation and education of allo-antigen specific postthymic T lymphocytes in vitro Kulova, L
1989
26 S p. 62-
1 p.
article
175 Meeting at a glance 1989
26 S p. xvii-xix
nvt p.
article
176 6.1-02 MHC and autoimmunity in Mexicans with IDDM Rodríguez, L
1989
26 S p. 46-
1 p.
article
177 MHC antigen expression on cultured human biliary epithelial cells Saidman, S.L
1989
26 S p. 114-
1 p.
article
178 3.2-05 MHC class II complexes do not undergo significant endocytosis David, J.E
1989
26 S p. 18-
1 p.
article
179 2.3-02 MHC-restriction analysis of antigen-specific helper T-cells derived from a caucasian individual with a DR4 (Dw15); DQw3 haplotype Celis, E
1989
26 S p. 13-
1 p.
article
180 2.2-04 Mixed lymphocyte reactivity in cynomologous macaques Heise, E.R
1989
26 S p. 10-
1 p.
article
181 MLR responses in unrelated individuals matched for HLA-B8, DR3, SC01 and one HLA-DR marker Awdeh, Z.L
1989
26 S p. 115-
1 p.
article
182 9.7-01 Molecular typing of variable number of tandem repeat (VNTR) loci in man Hsu, S
1989
26 S p. 108-
1 p.
article
183 7.1-01 Monoclonal antibodies to an IL-3 binding protein Morel, P.A
1989
26 S p. 61-
1 p.
article
184 9.7-02 Multiple restriction fragment length polymorphisms (RFLPs) associated with the chimpanzee V-A-B-D blood group system Rearden, A
1989
26 S p. 108-
1 p.
article
185 6.2-12 Mutagenesis and expression studies of the Dw14 (DR4) epitope Yamanaka, K
1989
26 S p. 55-
1 p.
article
186 8.4-06 Non inherited maternal antigens do not offer protection against sensitization after donor-specific transfusion Pohanka, E
1989
26 S p. 91-
1 p.
article
187 4.3-08 Nucleotide sequencing of the HLA-DR2B2 gene in blacks reveals a new allele Demopulos, J.T
1989
26 S p. 31-
1 p.
article
188 5.4-07 Oligonucleotide typing for DR beta and DQ beta Tonai, Richard
1989
26 S p. 42-
1 p.
article
189 4.3-03 Oligonucleotide typing of DR2-associated DQw1 subspecificities using PCR amplified genomic DNA McCusker, C.T
1989
26 S p. 29-
1 p.
article
190 Outstanding technologist award 1989
26 S p. xv-
1 p.
article
191 8.1-11 Platelet crossmatching in kidney transplantation Terashita, G.Y
1989
26 S p. 80-
1 p.
article
192 4.3-12 Polymorphism of the HLA-DR alleles in American blacks Hurley, C.K
1989
26 S p. 33-
1 p.
article
193 6.2-14 Polymorphism of the human T cell receptor Dβ2 genes and diabetes Hoover, M.L
1989
26 S p. 56-
1 p.
article
194 4.2-01 Polymorphism of three HLA-DR7-bearing major histocompatibility complex extended haplotypes Singal, D.P
1989
26 S p. 26-
1 p.
article
195 5.4-03 Precise definition of DRB1 and DRB3 in the DRw52 group by DNA typing with oligonucleotides Fernandez-Vina, M
1989
26 S p. 40-
1 p.
article
196 3.1-04 Production of monoclonal antibodies reactive with the new HLA class I molecules Geraghty, D
1989
26 S p. 16-
1 p.
article
197 Program committee and reviewers 1989
26 S p. i-
1 p.
article
198 8.1-17 Progress report on the ASHI/CAP histocompatibility survey program: Analysis of crossmatching and antibody identification results Marrari, Marilyn
1989
26 S p. 83-
1 p.
article
199 10.1-02 Propagation and characterization of lymphocytes infiltrating livers of patients with hepatic autoimmune diseases Saidman, S.L
1989
26 S p. 110-
1 p.
article
200 9.4-01 Quantitative measurement of tetanus toxoid-reactive human T lymphocytes Adams, P.W
1989
26 S p. 106-
1 p.
article
201 9.3-01 Recurrent spontaneous abortion (RSA) and flow cytometry (FACS) analyses Wagenknecht, D.R
1989
26 S p. 103-
1 p.
article
202 7.3-03 Relevance of DNA fragmentation in LAK cell-mediated cytotoxicity Brahmi, Z
1989
26 S p. 68-
1 p.
article
203 6.3-03 Relevance of MHC molecules on the surface of parasites in human neuro cysticercosis Trejo, V
1989
26 S p. 59-
1 p.
article
204 5.1-04 Reproducibility of HLA typing and cytotoxic scores on frozen T and B cells Ratner, L.J
1989
26 S p. 37-
1 p.
article
205 5.5-04 Resolution of an uninterpretable B cell crossmatch by a flow cytometric crossmatch (FCXM) Bray, R.A
1989
26 S p. 45-
1 p.
article
206 6.2-05 Rheumatoid-factor-negative polyarticular and pauciarticular juvenile arthritis are immunogenetically distinct Fernandez-Vina, M
1989
26 S p. 52-
1 p.
article
207 9.2-02 Role of protein kinase C translocation in non MHC-restricted cytotoxicity Shenov, A
1989
26 S p. 103-
1 p.
article
208 7.4-03 Sequences of T-cell receptor genes expressed by alloreactive T-cell clones Geiger, M.J
1989
26 S p. 71-
1 p.
article
209 8.1-01 Serological and biochemical definition of class I polymorphisms in cadaver renal transplantation Little, A.M
1989
26 S p. 75-
1 p.
article
210 1.3-04 Serologic detection of DQA specificities Barbetti, A.A
1989
26 S p. 5-
1 p.
article
211 10.1-05 Serologic evidence for unique MHC extended haplotypes in blacks Fraser, P
1989
26 S p. 112-
1 p.
article
212 Sheraton centre floor plans 1989
26 S p. viii-
1 p.
article
213 4.3-04 Southern analysis of DQw specificities with a short HLA-DQβ locus-specific, pDQβ141, cDNA probe Sood, S
1989
26 S p. 29-
1 p.
article
214 3.2-02 Specificity of anti-HLA class II antibodies in rheumatoid arthritis sera and synovial fluid Marnell, L.L
1989
26 S p. 17-
1 p.
article
215 8.1-06 Streamlined histocompatibility testing of cadaveric donor-recipient pairs Hsia, S
1989
26 S p. 78-
1 p.
article
216 6.2-03 Study of HLA-DR4 subsets in Israeli patients with rheumatoid arthritis Gao, X
1989
26 S p. 51-
1 p.
article
217 6.2-15 Synergy between histocompatibility antigens and T cell receptor in the anti-RO/SSA response of systemic lupus erythematosus Harley, J.B
1989
26 S p. 57-
1 p.
article
218 7.3-05 T cell-macrophage interaction via HLA class I antigens necessary for CD4+ T cell activation Egea, E
1989
26 S p. 69-
1 p.
article
219 4.3-01 The application of DNA techniques in tissue typing renal recipients and donors Middleton, D
1989
26 S p. 28-
1 p.
article
220 8.4-02 The development of lymphocytotoxic antibodies following renal transplantation correlates with graft failure Martin, S
1989
26 S p. 89-
1 p.
article
221 10.1-01 The distribution of HLA PI values in non-exclusion paternity cases involving blanks and antigen sharing Walker, R.H
1989
26 S p. 110-
1 p.
article
222 2.2-03 The DRw11/w13 family: A continuum of diversity Tang, T.F
1989
26 S p. 10-
1 p.
article
223 6.1-08 The immunogenetics of pemphigus vulgaris Ahmed, A.R
1989
26 S p. 49-
1 p.
article
224 8.4-01 The impact of recombinant erythropoietin (Epo) on pre-transplant recipient sensitization and transplant outcome Braun, W.E
1989
26 S p. 89-
1 p.
article
225 7.2-04 The predictive value of pre-transplant T and NK cell subset profiles as an index of host immune responsiveness Pullis, C
1989
26 S p. 65-
1 p.
article
226 8.2-02 The relationship of HLA match to rejection episodes and survival in heart transplantation patients Pollack, M.S
1989
26 S p. 84-
1 p.
article
227 7.5-03 The role of guanine nucleotide-binding proteins in human natural killer cytotoxic activities Gibboney, J
1989
26 S p. 73-
1 p.
article
228 8.2-06 The role of HLA matching in long term heart graft survival Radvany, R.M
1989
26 S p. 86-
1 p.
article
229 3.2-06 The role of signalling through the cytoplasmic domains of MHC class II molecules in antigen presentation St-Pierre, Y
1989
26 S p. 19-
1 p.
article
230 Transcriptional regulation of murine and human CD45 DiMartino, Jorge F
1989
26 S p. 114-
1 p.
article
231 4.1-06 Transcriptional regulation of the DRα gene in a mutant burkitt's lymphoma cell line Wei, M.L
1989
26 S p. 22-
1 p.
article
232 4.1-04 Transfection and expression of HLA class I and class II genes in the human B cell line WI-L2 NS Becker, Kevin G
1989
26 S p. 21-
1 p.
article
233 8.8-01 Transfusion-induced immunosuppression across different MHC barriers in mouse and man van Twuyver, E
1989
26 S p. 99-
1 p.
article
234 6.2-09 “Trans” or “cis” combinations of HLA-DQα2 or α6/HLA-DQβ2 or β6 chain genes promote the RO(SS-A)/LA(SS-B) autoantibody responses Reveille, J.D
1989
26 S p. 54-
1 p.
article
235 10.1-04 Use of Lotus 123™ and Allways™ to facilitate typing plate production Helgeson, M.A
1989
26 S p. 111-
1 p.
article
236 5.2-01 Use of monoclonal antibodies in the purification of human and bovine fetal islets of langerhans Conley, C.L
1989
26 S p. 37-
1 p.
article
237 8.2-04 Use of oligonucleotide probes to identify HLA-DR sequence polymorphism in bone marrow transplant recipients and donors Baxter-Lowe, L.A
1989
26 S p. 85-
1 p.
article
238 7.2-03 Variation in the allogeneic class II specific cytotoxic T cell repertoire in man Man, S
1989
26 S p. 64-
1 p.
article
239 4.1-10 YB-1 has two distinct binding sites for the HLA class II gene promoter region Giacoletto, K.S
1989
26 S p. 24-
1 p.
article
240 Young investigator awards 1989
26 S p. xv-
1 p.
article
                             240 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands